BioCorneaVet will be permanently resided in the recipient’s cornea after the remodeling process with more and more transparent cornea matrix without the use of anti-immunological agents anymore 6-12 months after the keratoplasty.But the autologous tissue would have to topically administer anti-immunological agents for a life time. While for the traditional conjunctiva flap with SIS, the optical negative prognosis and scarring are the unsatisfactory points.
BioCorneaVet™'s primary surgical method of implantation is by anterior lamellar keratoplasty (ALK or DALK). When covering corneal defects,BioCorneaVet™ promotes host corneal epithelial regeneration and matrix synthesis. Healing results when the cornea is fully restored in the aspects of structure and function as normal cornea.